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Endometriosis is associated with a range of pelvic-abdominal pain symptoms and infertility. It is a chronic disease that can have
a significant impact on various aspects of women’s lives, including their social and sexual relationships, work, and study. Despite
several international guidelines on the management of endometriosis, there is a wide variety of clinical practice in the management
of endometriosis, resulting in many women receiving delayed or suboptimal care. In this paper we discuss the possibilities and
benefits of using electronic health records for clinical research in the field of endometriosis. The development of a wide range of
clinical software for electronic patient records has made the registration of large datasets feasible and the integration of research
files and clinical files possible. Integration of global standards on registration of endometriosis care in electronic health records
could improve reporting of research data and facilitate the execution of large, multicentre randomized trials on the management of
endometriosis. These highly needed trials could bring us the evidence needed for the optimisation of management of women with
endometriosis.
1. Introduction
Endometriosis is a chronic, oestrogen-dependent inflamma-
tory condition characterized by the presence of endometrial-
like tissue outside the uterus [1]. The WERF EndoCost
study has shown that the cost arising from women with
endometriosis treated in referral centres is substantial, result-
ing in an economic burden that is at least comparable to the
burden associated with other chronic diseases, like diabetes
mellitus [2]. The clinical importance of endometriosis is also
reflected by the immense number of publications on this
subject. A Medline search for “endometriosis,” on 1 October
2014, gives more than 20 000 results, with more than 800
papers published per year since 2009.
This large body of scientific research in endometriosis
has led to important advances in the understanding of the
aetiology and pathogenesis of endometriosis, and these novel
insights hold promise for the development of new diagnostic
and therapeutic approaches for the future [3]. Nevertheless,
some key questions in the management of endometriosis
remain unanswered. A noninvasive diagnostic test with
high sensitivity and specificity is lacking, and there are few
or insufficient data from randomized trials to inform the
optimal management of endometriosis [4]. The 2013 ESHRE
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Guideline on management of women with endometriosis
emphasizes the need for optimisation of management of
women with endometriosis because there is a wide variety
of clinical practice in the management of endometriosis,
resulting in many women receiving delayed or suboptimal
care [2].
Since early development in the 1960s, there has been a
steady evolution towards the replacement of the paper based
medical records by electronic health records (EHR). During
the last 5–10 years, there has been a very rapid expansion to
the point where now, in some countries, nearly 90% of all
health records are digital [5]. The past decades of progress in
health information technology have reshaped the way health
care is carried out and how health data are being documented
[5]. Research and development projects are ongoing in
several countries around the world on the development of
infrastructure for national health information, the use of
patient generated health data in clinical practice, and the use
of EHR data in clinical research [5–7]. At present, healthcare
practice stores huge amounts of patient-specific information
in EHRs and databases [5]. The use of these electronic
health data holds great promise to contribute to improving
clinical practice and medical research, to support health care
planning and to facilitate quality control of medical care.
In this paper, we discuss the possibilities and benefits of
using electronic health records for clinical research in the field
of endometriosis. In the first part, we discuss the key elements
that should be included in electronic health records from the
perspective of clinical research needs in endometriosis. In
the second part, we describe how electronic health records
could be optimally designed for the integration of clinical care
and research. In the last two paragraphs we discuss the costs,
possible savings, benefits, and limitations of implementing
integrated research files and EHRs on a large scale.
2. Necessary Data from a Research Perspective
In the mid-1990s, in response to concerns about quality of
reporting data from RCTs, an international group developed
the Consolidated Standards of Reporting Trials (CONSORT)
statement [8]. The CONSORT statement, published in 1996
and revised in 2001, is a set of guidelines designed to
improve the reporting of RCTs [8, 9]. In a systematic review,
the beneficial effect on reporting RCTs by adoption of the
CONSORT criteria has been demonstrated [10]. Since 1996,
the CONSORT statement has been extended to RCTs of
nonpharmacologic treatments [11]. Furthermore, additional
guidelines have been published for other types of studies,
for example, the STROBE-statement (STrengthening the
Reporting of OBservational studies in Epidemiology) for
observational studies and the PRISMA-statement (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses)
for systematic reviews and meta-analyses [12, 13].
Endometriosis has a significant effect on various aspects
of women’s lives, including their social and sexual relation-
ships, work, and study [2]. Women with endometriosis can
have a range of pelvic-abdominal pain symptoms, includ-
ing dysmenorrhoea, dyspareunia, heavy menstrual bleeding,
nonmenstrual pelvic pain, pain at ovulation, dyschezia, and
dysuria, as well as chronic fatigue [1]. Endometriosis is also
associated with infertility, with a strong association between
severity of disease and impact on fertility [1].
For research databases and randomised trials, well-
characterised and relevant outcomemeasures are very impor-
tant. Recommendations for pain scoring in clinical trials on
endometriosis have been published but they are lacking other
important aspects of the disease [14]. For example, the lack
of international agreement on terms and definitions to assess
clinical outcome in the surgical treatment of endometriosis
has led to the use of a multitude of different outcome
measures and the lack uniformity in the reporting of surgical
data. In a systematic review of 2011 on the surgical man-
agement of deep endometriosis with colorectal extension,
comparison between surgical techniques was impossible due
to incomplete and inadequate reporting in the trials under
investigation [15]. Out of 49 studies included in that review,
only one study reported data on all the outcome variables
under review (complications, pain, quality of life, fertility,
and recurrence) [15]. In another systematic review of 2010
on bowel resection for deep endometriosis,meta-analysis was
again impossible due to lack of uniformity in reporting of data
[16].
Recently the World Endometriosis Research Foundation
(WERF) has launched the WERF Endometriosis Phenome
and Biobanking Harmonisation Project (EPHect) [17–21].
The purpose of EPHect is to facilitate and enable large-
scale, cross-centre, longitudinal, epidemiologically robust,
biomarker and treatment target discovery research in
endometriosis through the development of a consensus on
detailed clinical phenotyping (phenome) data to be collected
from women with endometriosis and on standard operating
procedures (SOPs) for banking of biological samples from
women with endometriosis and controls, with respect to col-
lection, transport, processing, and long-term storage [17–21].
The global consensus of detailed phenotypic characterization
and standard operating procedures is anticipated to pro-
vide a platform to interpret biochemical, genetic/epigenetic,
genomic, and quality of life data relevant to endometriosis
symptoms and targeted therapies [17–21]. Projects such as the
WERFEPHect are very important to standardize reporting in
endometriosis research and similar, international, initiatives
with detailed guidelines for standardised reporting of other
aspects of endometriosis research, such as the medical and
surgical treatment of endometriosis, are needed to improve
and harmonize reporting.
In conclusion, it can be stated that an ideal clinical
endometriosis research file incorporates outcome measures
of all relevant aspects of endometriosis. Detailed guide-
lines for data to be collected in clinical endometriosis
research, such as the EPHect, should be developed for all
aspects of endometriosis research and form the basis of any
endometriosis research file. Furthermore attention should be
paid to report data according to international standards such
as CONSORT.
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3. Electronic Health Record (EHR): Integration
of Research and Clinical Practice
Several studies have demonstrated that implementing an
EHR can yield real benefits in terms of increased deliv-
ery of care based on guidelines, enhanced monitoring and
surveillance activities, reduction of medication errors, and
decreased rates of utilization for potentially redundant or
inappropriate care [22]. The success of EHRs depends on
the quality and completeness of the information available to
health care professionals in making decisions about patient
care and in the communication between health care profes-
sionals during patient care. It is important therefore to assess
the data quality if information is entered in electronic systems
by different health care professionals [6].
The main challenge in clinical practice is how relevant
and essential clinical research items for endometriosis can
be integrated in an electronic health record which remains
user friendly for daily clinical practice. To use EHR systems
efficiently for clinical research, a number of features are
required that, unfortunately, have not yet been implemented.
Functions are required to ensure the correctness, complete-
ness, and accuracy of the data within the EHR systems; there
also has to be a structured or coded use of nomenclature to
allow data extraction [5]. So far, EHRs have largely consisted
of unstructured, narrative text and to a small extent of
structured coded data. In the future it will be necessary to
implement more systematic terminologies and codes so that
the data contained in EHRs can be put to better use [6].
Two widely used clinical healthcare terminology databases
are the ICD (International Classification of Diseases) and
SNOMED-CT (systematized nomenclature of medicine clin-
ical terms) developed and supported by the WHO (World
Health Organization) and IHTSDO (International Health
Terminology Standards Development Organisation), respec-
tively [23, 24]. Using standardized nomenclature in EHRs is
important from a research perspective: the development of
strategies for automatic or convenient use of this nomen-
clature is essential for the integration of routine clinical
practice and scientific research. Furthermore, the consistent
use of standardized nomenclature not only facilitates data
extraction from EHRs, but also creates the possibility to
exchange, integrate, and compare data from different EHRs.
This “semantic interoperability” is on top of the Health
Informatics agenda. It targets the preservation of meaning
between heterogeneous patient-related and aggregated popu-
lation data across different vocabularies and coding systems.
In order to meet this demand, the WHO and IHTSDO have
decided to create a Common Ontology [25].
4. Benefits and Limitations of EHR
Use in Routine Clinical Practice and
Clinical Research
The introduction from an electronic health record has several
benefits in comparison to a paper based patient record.
The EHR enables centralized collection of data instead of
the fragmented paper records due to patient care provided
at multiple locations [26]. Furthermore EHRs can decrease
medical errors, facilitate detection of adverse health events,
and increase the safety of the process of giving medications
[26]. Finally the EHR has helped quality control and health
care planning through the possibility of evaluation of care
based on date extracted from patient records [26].
The next challenge is to adapt these clinical EHRs for use
in clinical research, reducing the need to develop separate
clinical research databases that require duplication of patient
data.High quality research requires very rigorous registration
of clinical data from the first patient contact till long term
follow-up after treatment. A possible method is to integrate
selectively clinical research in an existing EHR. In the context
of endometriosis, this could be done by integrating general
clinical data, as outlined in general guidelines for clinical
research (i.e., CONSORT and STROBE), and endometriosis-
specific data, as presented in endometriosis-specific guide-
lines. In Tables 1 and 2 a summary of recommendations for
the reporting of medical and surgical trials in endometriosis
is presented [14, 27]. In Table 3 an overview of the WERF
EPHect project is provided. Since it is impossible to record
too many research data in clinical practice, choices have to
be made by each research group about essential and optional
items. Ideally, a link should be constructed between the EHR
and direct web based reporting of patient reported outcomes.
This will become increasingly important in long term follow-
up of patients with endometriosis, in order to address the
problem of low response rates, leading to substantial amounts
of missing data and selection bias.
5. Costs and Possible Savings of
an Electronic Research File
The potential health and financial benefits of widespread
implementation of health information technology (HIT) in
the US has been estimated to be more than $81 billion
annually, by improving health care efficiency and safety [28].
However, this estimation has been challenged, since these
potential savings have not been realized in the USA [29] or
in the UK [30, 31].
This inability to realise financial benefits through the
implementation of HIT can be explained largely by inad-
equate management and development strategies by the IT
industry [29]. Indeed, few health IT vendors make products
that are easy to use, resulting in complaints from many
doctors and nurses that health IT systems slow them down
[29].
In contrast, EHR systems can be very successful if they are
developed in collaboration with medical staff and regularly
adapted based on feedback from clinical practice [28, 29].
This strategy makes the EHR-system more user friendly
and improves quality of care and patient outcomes at a
significantly lower cost than most electronic health care
systems [29].
At present, no data are available about cost and possible
cost savings from an electronic research file integrated within
the EHR used in daily practice. From our own experience
we believe that several important factors need to be taken
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Table 1: Recommendations for clinical trials in endometriosis.
Entry criteria
Surgical diagnosis of endometriosis in the last 5 years
Pain symptoms
Data capture at baseline:
(i) ASRM staging
(ii) baseline pain scores over at least 2 menstrual cycles
(iii) EHP-30
(iv) previous treatments and responses
Primary outcome measures
Daily ratings of pelvic pain
Daily ratings of dysmenorrhea
Ratings on an 11-point NRS
Secondary outcome measures
B & B with separate scores for each domain, administered weekly for 6 weeks, then monthly until 6 months, and then at 9, 12, 18, and
24 months
EHP-30 with separate and total scores, administered at the same tie points as the B & B
Use of rescue analgesia/therapies including an NRS before us and a record of the indication
Study specific adverse event questionnaires with direct questions and free text, administered at the same time points as the B & B
Detailed information as per the CONSORT guidelines, including
(i) the recruitment process
(ii) the number of participants who were excluded and why
(iii) the number of candidates who chose not to enter the trial and why
(iv) the use of prohibited concomitant mediations and other protocol deviations
(v) the number and reasons for withdrawal from each treatment group
(vi) the types rates and reasons for nonadherence with treatment in each group
Tertiary outcome measures
Daily NRS of three symptoms the patient feels are important for her, for example, dyspareunia, dyschezia, fatigue, and so forth
Adapted from Vincent et al., 2010 [14].
B & B = Biberoglu and Behrman.
NRS = numerical rating scale.
into account in cost calculations for an electronic clinical
research file. First of all, there is the time spent by researchers
extracting their data from patients files. As described above,
data in EHRs are very rarely coded and as such automated
data extraction is not possible. In the context of case control
trials, retrospective evaluation of EHRs is needed in order to
retrieve essential and relevant clinical research information
from cases and controls, a very time consuming and frus-
trating process. In the context of prospective cohort studies,
this situation leads to double registration of clinical data by
the medical staff on the one hand and the researchers on the
other hand. Secondly, the extra time required to enter data for
research purposes in EHRs can lead to improvement in their
accuracy and completeness and serve the quality of clinical
care as well.
In our hospital we have chosen to incorporate as many
research data as possible in our electronic health record
used in daily practice. Based on suggestions and feedback
from both researchers and medical staff we have tried to
minimize the burden of extra work/time and maximize the
gains for both clinical care and research aims. We estimate
that more detailed clinical records and facilitation of data
extraction from this clinical database for research will be cost
effective, in the sense that that the extra time spent by the
medical staff will be compensated by the time gained in data
extraction for research or quality control purposes. Our effort
is also expected to facilitate retrospective studies and data
registration for our Endometriosis Biobank [32].
6. Conclusion
The technological advancements of the last decades in EHRs
have supported improvement of clinical care and research.
These new technologies have facilitated the analysis of health
care processes and influencedmedial decisionmaking, health
care planning, and medical research. The development of
a wide range of clinical software for electronic patient
records has enabled the registration of large datasets and the
integration of medical records with clinical research files.
A fast and user friendly system is needed to enter clinical
research data and patient reported outcomes in EHRs, linking
clinical practice to clinical research in an online modal-
ity. General (CONSORT, STROBE, . . .) and endometriosis
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Table 2: Recommendations for designing and reporting studies in the surgical treatment of DIE.
Title and abstract
Study type Clearly define the study type (e.g., prospective, retrospective)
Introduction
Background Scientific background and explanation of rationale
Methods
Participants
Previous therapeutic surgery: type (diagnostic, therapeutic), number, laparoscopy or laparotomy,
endometriosis-related or not
Indication for surgery: pain, child wish completed, child wish uncompleted, child wish absent
Sample size and power calculation
Interventions
Endometriosis staging according to ASRM classification; operation time; length of hospital stay;
multidisciplinary team including details on which surgeon did which surgery; clear description of the surgical
technique according to the following definitions: shaving: superficial peeling of bowel serosal and subserosal
endometriosis (with diathermy or laser), superficial excision: selective excision of the bowel endometriosis
lesion without opening of the bowel wall, full thickness disc excision: selective excision of the bowel
endometriosis lesion with opening followed by closure of the bowel wall, and bowel resection anastomosis:
resection of a bowel segment affected by endometriosis followed by anastomosis report type and number of
concomitant procedures in detail
Follow-up period
Define the period of follow-up (in months)
Details on the follow-up procedure (e.g., telephone interview, questionnaire, and clinical evaluation)
Patients lost during follow-up period
Pain measurement
Define the method used for pain measurement: presurgery and postsurgery, number of patients using hormonal
treatment at the time of pain assessment, 11-point numerical scale for the assessment of menstrual pain
(dysmenorrhea), nonmenstrual pain, dyspareunia; use of other methods (interviews, questionnaires): provide
full details.
Patient-based or doctor-based
QOL measurement Define the method used for QOL measurement (e.g., EHP-30, SF-36, and EQ-5D)
Fertility rate
Number of patients with history of infertility
Number of patients wishing to conceive passively (wish for reservation/restoration of fertility during surgery,
without well-defined child wish at the time of surgery); number of patients wishing to conceive actively with a
well-defined child wish in the near future; number of patients wishing to conceive actively with a well-defined
child wish in the distant future
Recurrence rate
Define recurrence: (1) symptom recurrence based on patient history, but no proof of recurrence by imaging and
surgery; (2) endometriosis recurrence based on imaging: in patients with or without symptoms (pain and
infertility). Recurrence is then likely based on noninvasive imaging (e.g., ultrasound and MRI); (3) surgical
reintervention without recurrence of endometriosis: in patients with recurrent symptoms, surgery without
visual diagnosis of endometriosis, and with either normal pelvis or other abnormalities (e.g., adhesions); (4)
recurrence of visual endometriosis without histological proof: during laparoscopy endometriosis is visually
observed but either not biopsied or biopsied without histologically proven endometriosis; (5) recurrence of
histologically proven endometriosis: during laparoscopy endometriosis is visually observed and confirmed
histologically. Suspicious recurrent endometriosis is present if the criteria for categories 1 and 2 were met.
Proven recurrent endometriosis is present if the criteria for categories 4 and 5 were met. Additional surgery
without evidence for endometriosis is present if the criteria for category 3 are met.
Statistical methods Statistical methods used; life table analysis methods; handling of patients lost for follow-up
Results
Histological
confirmation
Report degree of endometriosis invasion in bowel
Report the median length of the resected colorectal segments (in cm)
Report the median largest diameter of the lesions (in cm)
Report the number of positive margins over the number of resected bowel specimens; report the number of
patients with at least one positive margin of the bowel resection specimen
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Table 2: Continued.
Complications
Report all major complications and their clinical management [surgery
(specify type of surgery), medical, and expectant] including rectovaginal fistulae,
anastomotic leaks, postoperative stomas, abscesses, and postoperative
bleedings in absolute numbers
Fertility rate
Report cumulative pregnancy rate (life table analysis)
Number of women who conceived
Median time to conceive after surgery
Mode of conception: spontaneous or medically assisted conception (ovulation induction; intrauterine
insemination with or without ovarian stimulation; assisted reproduction: IVF and ICSI; fresh cycle or cryocycle;
egg reception or embryo reception)
Live birth rate; ectopic pregnancy rate, miscarriage rate, and clinical pregnancy rate
Recurrence rate Report cumulative recurrence rate (life table analysis)
Discussion
Interpretation Interpretation of the results, taking into account study hypotheses, sources of potential bias or imprecision, andthe dangers associated with the multiplicity of analyses and outcomes.
Generalizability External validity of the trial findings
Overall evidence General interpretation of the results in the context of current evidence
Adapted fromMeuleman et al., 2012 [27].
Table 3: Overview of WERF EPHect.
Project I
Surgical phenotype data collection in endometriosis research
Provides a standard recommended and a minimum required surgical form (SSF and MSF) to collect data on the
surgical phenotype of endometriosis.
Project II
Clinical and covariate phenotype data collection in endometriosis research
Provides a standard recommended and minimum required self-administered endometriosis patient
questionnaire (EPQ) to capture detailed clinical and covariate data.
Project III
Fluid biospecimen collection, processing, and storage in endometriosis research
Provides recommended and minimum required standard operating procedures for biofluid collection,
processing, and storage in endometriosis research.
Project IV
Tissue collection, processing, and storage in endometriosis research
Provides standard recommended and minimum required standard operating procedures for tissue collection,
processing, and storage in endometriosis research.
Summary of Becker et al., 2014 [17], Vitonis et al., 2014 [18], Rahmioglu et al., 2014 [19], and Fassbender et al., 2014 [20].
specific (WERF EPHECT, . . .) international standards are
needed to decide which data should be collected for which
type of research. Ideally all data should automatically be
coded in internationally used clinical healthcare terminology
and be subject to quality control tools assessing completeness,
accuracy, and other dimensions.
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